Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Mazor

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cellular & Molecular Immunology|October 20, 2015
Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivoRonit Mazor, Devorah Crown, Selamawit Addissie, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2025
AAV2 delivery of the <i>saCas9</i> gene results in presentation of an HLA-A<sup>∗</sup>02:01-restricted T cell epitope potent to induce T cell cytotoxicitySusana S Najera, Annalisa Nicastri, Sojin Bing, et al.
Cellular Immunology|January 15, 2017
Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38Ronit Mazor, Gilad Kaplan, Dong Park, et al.
The AAPS Journal|November 1, 2016
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 ImmunotoxinRonit Mazor, Selamawit Addissie, Youjin Jang, et al.
Radiation Research|December 28, 2007
Increased levels of numerical chromosome aberrations after in vitro exposure of human peripheral blood lymphocytes to radiofrequency electromagnetic fields for 72 hoursRonit Mazor, Avital Korenstein-Ilan, Alexander Barbul, et al.
Oncotarget|May 12, 2016
Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activityRonit Mazor, Masanori Onda, Dong Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2014
Removing T-cell epitopes with computational protein designChris King, Esteban N Garza, Ronit Mazor, et al.
Molecular Cancer Therapeutics|October 8, 2015
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing TumorsRonit Mazor, Jingli Zhang, Laiman Xiang, et al.
Gene Therapy|May 5, 2025
Unveiling the sex bias: higher preexisting and neutralizing titers against AAV in females and implications for gene therapyStephanee Warrington, Trish T Hoang, Morten Seirup, et al.
Nature Biomedical Engineering|November 23, 2023
Rational immunosilencing of a promiscuous T-cell epitope in the capsid of an adeno-associated virusSo Jin Bing, Morten Seirup, Trish T Hoang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cellular & Molecular Immunology|October 20, 2015
Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivoRonit Mazor, Devorah Crown, Selamawit Addissie, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2025
AAV2 delivery of the <i>saCas9</i> gene results in presentation of an HLA-A<sup>∗</sup>02:01-restricted T cell epitope potent to induce T cell cytotoxicitySusana S Najera, Annalisa Nicastri, Sojin Bing, et al.
Cellular Immunology|January 15, 2017
Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38Ronit Mazor, Gilad Kaplan, Dong Park, et al.
The AAPS Journal|November 1, 2016
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 ImmunotoxinRonit Mazor, Selamawit Addissie, Youjin Jang, et al.
Radiation Research|December 28, 2007
Increased levels of numerical chromosome aberrations after in vitro exposure of human peripheral blood lymphocytes to radiofrequency electromagnetic fields for 72 hoursRonit Mazor, Avital Korenstein-Ilan, Alexander Barbul, et al.
Oncotarget|May 12, 2016
Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activityRonit Mazor, Masanori Onda, Dong Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2014
Removing T-cell epitopes with computational protein designChris King, Esteban N Garza, Ronit Mazor, et al.
Molecular Cancer Therapeutics|October 8, 2015
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing TumorsRonit Mazor, Jingli Zhang, Laiman Xiang, et al.
Gene Therapy|May 5, 2025
Unveiling the sex bias: higher preexisting and neutralizing titers against AAV in females and implications for gene therapyStephanee Warrington, Trish T Hoang, Morten Seirup, et al.
Nature Biomedical Engineering|November 23, 2023
Rational immunosilencing of a promiscuous T-cell epitope in the capsid of an adeno-associated virusSo Jin Bing, Morten Seirup, Trish T Hoang, et al.
Pageof 3